MedWatch

Leo Pharma introduces whistleblower system

The Danish drug manufacturer Leo Pharma will be launching a new whistleblower system, at the same time the company extends its anti-corruption policy, due in part to strict regulations from the UK.

Foto: Colourbox

One of Denmark’s largest medical outfits, Leo Pharma, is currently implementing a new whistleblower system in the company.

“We are implementing a whistleblower system and expect to hand in an application to The Danish Data Protection Agency before Christmas. Those are the rules, as we are dealing with sensitive personal information, and we are collaborating with experts within this area. After submitting the application, it could be 5-6 months before an approval,” Nina Henning, VP of Corporate Affairs, tells Medwatch.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier